Inventor
METT IGOR
IL44 patents
⚠️ This page may combine multiple inventors who share the name “METT IGOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
QUARK PHARMACEUTICALS INC
14 patentsUS7626015B2Dec 1, 2009
Therapeutic uses of inhibitors of RTP801L
QUARK PHARMACEUTICALS INC113 citations99
US9932578B2Apr 3, 2018
Double-stranded oligonucleotide molecules to P53 and methods of use thereof
QUARK PHARMACEUTICALS INC31 citations94
US9121020B2Sep 1, 2015
Methods for treating eye disorders
QUARK PHARMACEUTICALS INC20 citations90
US8017764B2Sep 13, 2011
Therapeutic uses of inhibitors of RTP801L
QUARK PHARMACEUTICALS INC10 citations84
US9701961B2Jul 11, 2017
Methods for treating eye disorders
QUARK PHARMACEUTICALS INC3 citations70
US8614311B2Dec 24, 2013
RTP801L siRNA compounds and methods of use thereof
QUARK PHARMACEUTICALS INC2 citations63
US10421962B2Sep 24, 2019
Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof
QUARK PHARMACEUTICALS INC1 citations62
US9611474B2Apr 4, 2017
Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof
QUARK PHARMACEUTICALS INC1 citations62
US8344104B2Jan 1, 2013
Screening systems utilizing RTP801
QUARK PHARMACEUTICALS INC1 citations60
US8034575B2Oct 11, 2011
Screening systems utilizing RTP801
QUARK PHARMACEUTICALS INC1 citations60
US7723052B2May 25, 2010
Screening systems utilizing RTP801
QUARK PHARMACEUTICALS INC3 citations59
US9822362B2Nov 21, 2017
Compositions and methods for treating lung disease and injury
QUARK PHARMACEUTICALS INC1 citations51
US9796979B2Oct 24, 2017
Oligonucleotide modulators of the toll-like receptor pathway
QUARK PHARMACEUTICALS INC0 citations51
US10781449B2Sep 22, 2020
Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof
QUARK PHARMACEUTICALS INC0 citations41
YEDA RES & DEV
13 patentsUS6579697B1Jun 17, 2003
Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
YEDA RES & DEV32 citations92
US6602993B2Aug 5, 2003
DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule
YEDA RES & DEV19 citations91
US6555111B2Apr 29, 2003
Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies
YEDA RES & DEV16 citations91
US6262239B1Jul 17, 2001
TNF receptor-specific antibodies
YEDA RES & DEV29 citations91
US6232446B1May 15, 2001
TNF ligands
YEDA RES & DEV33 citations91
US7101675B2Sep 5, 2006
Modulators of regulatory proteins
YEDA RES & DEV18 citations88
US7485456B1Feb 3, 2009
Modulators of TNF receptor associated factor (TRAF), their preparation and use
YEDA RES & DEV6 citations71
US7186682B2Mar 6, 2007
Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
YEDA RES & DEV4 citations62
US6355780B1Mar 12, 2002
Antibodies to the death domain motifs of regulatory proteins
YEDA RES & DEV2 citations58
US7455977B2Nov 25, 2008
Methods of determining the level of human TBP-II with anti-TBP-II antibody
YEDA RES & DEV0 citations51
US7323548B2Jan 29, 2008
Modulators of the function of FAS/APO1 receptors
YEDA RES & DEV0 citations51
US7108999B1Sep 19, 2006
Modulators of the function of FAS/AP01 receptors
YEDA RES & DEV0 citations51
US6808891B2Oct 26, 2004
Modulators of the function of FAS/APO1 receptors
YEDA RES & DEV0 citations51
NITTO DENKO CORP
5 patentsUS9206424B2Dec 8, 2015
Modulation of HSP47 expression
NITTO DENKO CORP21 citations92
US9456984B2Oct 4, 2016
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP10 citations84
US10196637B2Feb 5, 2019
Retinoid-lipid drug carrier
NITTO DENKO CORP7 citations83
US10093923B2Oct 9, 2018
Modulation of HSP47 expression
NITTO DENKO CORP5 citations83
US10195145B2Feb 5, 2019
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP4 citations73
FEINSTEIN ELENA
5 patentsUS8614309B2Dec 24, 2013
Double-stranded RNA directed to CASP2 and methods of use thereof
FEINSTEIN ELENA11 citations82
US9222087B2Dec 29, 2015
Therapeutic uses of inhibitors of RTP801L
FEINSTEIN ELENA2 citations63
US8278287B2Oct 2, 2012
siRNA compounds for inhibiting NRF2
FEINSTEIN ELENA5 citations63
US8765931B2Jul 1, 2014
Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 gene
FEINSTEIN ELENA1 citations59
US9487778B2Nov 8, 2016
Oligonucleotide modulators of the toll-like receptor pathway
FEINSTEIN ELENA1 citations51